The WISER Study: Web Based Methods for Enhancing Resilience

Sponsor
Duke University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05636072
Collaborator
(none)
8,000
1
2
38
210.6

Study Details

Study Description

Brief Summary

This is a research study to find out if web-based resilience tools can increase well-being.

Enrolled participants will try out one or more brief positive psychology tools. The tools ask participants to reflect on positive experiences or to do an activity (e.g., write a letter of gratitude). The study is entirely online and participants will be prompted to participate via email or text messages.

The study team is interested in the effects of the tools on stress, depression, and burnout in adults. A set of brief surveys are administered before and after using the tool, and again at follow-up periods (e.g., 1, 3, 6 and 12 months). Surveys are collected electronically using the secure, HIPAA compliant Qualtrics survey software.

There is no direct benefit to participants for participating in this research study aside from the potential to experience improvements in well-being. Risks are minimal and include the potential to feel emotional or psychological distress when asked questions related to burnout.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: WISER
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
8000 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Waitlist control group RCTWaitlist control group RCT
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
The WISER Study: Web Based Methods for Enhancing Resilience
Actual Study Start Date :
Nov 1, 2022
Anticipated Primary Completion Date :
Dec 31, 2025
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Treatment Immediately

Participants will engage in well-being tools immediately for 1-week.

Behavioral: WISER
Participants will engage in one or more positive psychology well-being tool(s).

No Intervention: Waitlist Control

Participants will wait 1 week to begin the well-being tools.

Outcome Measures

Primary Outcome Measures

  1. Change in Emotional Exhaustion as measured by the 5-item Emotional Exhaustion Scale [Baseline, Day 8, and 1, 6, and 12 month follow-ups]

    Survey scores are measured on a 1-5 Likert-like agreement scale.

Secondary Outcome Measures

  1. Change in Emotional Recovery as measured by the 4-item Emotional Recovery Scale [Baseline, Day 8, and 1, 6, and 12 month follow-ups]

    Survey scores are measured on a 1-5 Likert-like agreement scale.

  2. Change in Work-life Integration as measured by the 7-item Work-life Integration Scale [Baseline, Day 8, and 1, 6, and 12 month follow-ups]

    Survey scores are measured with a 1-4 frequency of behaviors scale.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adults 18 and over are considered eligible for the study. A sub-sample will include employees (including but not limited to frontline caregivers, support staff and management) of the Duke University Health System, as well as external health systems. All participants will be invited to participate in one or more of the online tools. The investigators will allow the participation of any clinical areas/healthcare worker groups whose leaders express interest in building resilience. The investigators are targeting healthcare workers for recruitment in the study, but adults 18+ are eligible to participate in any of these tools. Identification as a healthcare worker or not is part of data collection in every tool.
Exclusion Criteria:
  • Adults who are not proficient in English, do not have basic computer skills, or who have prohibitive vision or hearing disabilities will be excluded from this study as they will be incapable of full participation in the intervention and/or the survey process.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Duke University Health System Durham North Carolina United States 27707

Sponsors and Collaborators

  • Duke University

Investigators

  • Principal Investigator: John B Sexton, PhD, Duke

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Duke University
ClinicalTrials.gov Identifier:
NCT05636072
Other Study ID Numbers:
  • Pro00063703
First Posted:
Dec 5, 2022
Last Update Posted:
Dec 6, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Duke University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 6, 2022